Emilio Emini, Ph.d.
Scientific Advisor
immunology
ImmunoBiology
Mongolia
Biography
Emilio A. Emini, Ph.D., is a scientific advisor to Vir. Since July 2015, he has served as the director of the HIV program at the Bill & Melinda Gates Foundation. Prior to his current role, Dr. Emini served as senior vice president of vaccine research and development at Pfizer Inc., a position into which he transitioned after Pfizer’s acquisition of Wyeth Pharmaceuticals in late 2009. At Wyeth, he led the R&D efforts that resulted in licensure of Prevenar 13, Pfizer’s vaccine for the prevention of pneumococcal disease.
Research Interest
Emilio A. Emini, Ph.D., is a scientific advisor to Vir. Since July 2015, he has served as the director of the HIV program at the Bill & Melinda Gates Foundation. Prior to his current role, Dr. Emini served as senior vice president of vaccine research and development at Pfizer Inc., a position into which he transitioned after Pfizer’s acquisition of Wyeth Pharmaceuticals in late 2009. At Wyeth, he led the R&D efforts that resulted in licensure of Prevenar 13, Pfizer’s vaccine for the prevention of pneumococcal disease.
